Internal Medicine, Gastroenterology · Anaheim, CA
NPI
1013088046
Since 2006
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
441 N Lakeview Ave
Anaheim, CA, 92807
Phone (888) 988-2800
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$623K
964 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Syeda S Husain prescribed most often to Medicare patients was Gavilyte-C (Peg3350/Sod Sulf,bicarb,cl/Kcl), with 220 prescriptions and refills. In total Syeda S Husain wrote 964 Medicare prescriptions that cost $623K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-11-29.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Gavilyte-C Peg3350/Sod Sulf,bicarb,cl/Kcl | 220 | 220 | 217 | $5,606 |
| Omeprazole Generic | 176 | 528 | 89 | $1,778 |
| Pantoprazole Sodium Generic | 62 | 151 | 23 | $874 |
| Mesalamine Generic | 55 | 152 | 21 | $21K |
| Entecavir Generic | 44 | 134 | 16 | $2,312 |
| Adefovir Dipivoxil Generic | 42 | 48 | Under 11 | $25K |
| Ursodiol Generic | 25 | 79 | Under 11 | $5,530 |
| Sucralfate Generic | 24 | 29 | 11 | $1,863 |
| Famotidine Generic | 19 | 31 | Under 11 | $642 |
| Creon Lipase/Protease/Amylase | 17 | 45 | Under 11 | $53K |
| Potassium Chloride Generic | 15 | 28 | Under 11 | $499 |
| Carvedilol Generic | 15 | 41 | Under 11 | $154 |
| Metronidazole Generic | 14 | 14 | 14 | $129 |
| Prednisone Generic | 14 | 23 | Under 11 | $200 |
| Spironolactone Generic | 13 | 40 | Under 11 | $461 |
Brand drugs: - claims; generic drugs: 838 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Syeda S Husain were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.